Fig. 1 · Structure

Documents & Downloads

Crocin II

Cat. No. A14530 CAS 55750-84-0
Crocin II is extracted from Crocus sativus L.

In Stock

Publications for Crocin II

1 publication citing this product

  1. Inoue E, .et al. , J Nat Med, 2018, Jan;72(1):274-279 PMID: 29147836

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Bioactivity / Mechanism

In a surface plasmon resonance assay with immobilized human ANGPTL8, author-designated Crocin II yielded a fitted dissociation constant (K_D) of 1.276 μmol·L−1; the Crocin I comparator yielded 16.8 μmol·L−1. These are assay-specific binding estimates, not cellular IC50 values or evidence of target selectivity. [1]

Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.

Target & Activity

Target Activity Value
iNOS  

Cellular Effect

Cell Line Activity Value Description Reference
RAW264.7 IC50 > 100 μM Inhibition of nitric oxide production in lipopolysaccharide-activated mouse RAW264.7 cells by Griess reaction based method [PMID: 23305920]

In Vitro Studies

SPR binding of Crocin II to human ANGPTL8

Biochemical assay · Immobilized human ANGPTL8 on a CM5 sensor chip; Biacore S200 SPR analysis [1]

Concentration-dependent sensorgrams were fitted using a 1:1 Langmuir kinetic binding model. Reported K_D was lower for Crocin II than for Crocin I. This establishes the reported assay fit, without establishing selectivity or a cellular degradation mechanism.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
Fitted binding affinity for immobilized human ANGPTL8K_D 1.276 μmol·L−1[1]
Crocin I comparator binding affinity for immobilized human ANGPTL8K_D 16.8 μmol·L−1[1]

Literature-Reported Treatment Conditions

Treatment concentration
0.3125, 0.625, 1.25, 2.5 and 5 μmol·L−1 Crocin II; same series for Crocin I (Fig. 1h legends)
Method
Gradient analyte concentrations injected over immobilized human ANGPTL8; fitted with Biacore S200 Evaluation Software. PBSP running buffer is specified in the SPR methods.
Reported limits
Analyte solvent, explicit blank/reference-channel subtraction, fit uncertainty and SPR-specific replicate definition are not stated in the acquired SPR methods/caption. Overall Fig. 1 caption says mean ± SEM, n = 3, without identifying the replicate basis of the kinetic fit. No exposure duration is assigned from the plotted time axis.
Methods and source locations

Compound reported in the paper: Crocin II; Compound label in the paper: Crocin II (author designation; compared with Crocin I)

Applies to author-designated Crocin II in this SPR experiment; does not certify an Adooq lot, chemical purity or isomer composition.

Materials and methods, “Surface plasmon resonance (SPR) assay”; Fig. 1h and caption; Results, first subsection; Animals (Crocin II sourcing); Discussion (Crocin I/II structural distinction)

Fitted binding affinity for immobilized human ANGPTL8: SPR; multi-cycle kinetic analysis and 1:1 Langmuir model — Fig. 1h, lower sensorgram and printed K_D; Results, first subsection

Crocin I comparator binding affinity for immobilized human ANGPTL8: SPR; multi-cycle kinetic analysis and 1:1 Langmuir model — Fig. 1h, upper sensorgram and printed K_D; Results, first subsection

Specifications

Manufacturer Adooq Bioscience
CAS Number 55750-84-0
Formula C38H54O19
Molecular Weight 814.82
Synonyms Crocin 2; Crocin B; Tricrocin
SMILES
C/C(=C\C=C\C=C(/C)\C=C\C=C(/C)\C(=O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O)O)O)/C=C/C=C(\C)/C(=O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 92 mg/mL (112.9 mM)

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Research References

  1. [1] Rongtian Zhang, Kongdong Li, Ziting Zhao, et al. Crocin II alleviates metabolic dysfunction-associated steatotic liver disease by enhancing autophagic degradation of ANGPTL8 Targetome (2026). DOI: 10.48130/targetome-0026-0012 Source material

Publications

1 publication citing this product

  1. Inoue E, .et al. , J Nat Med, 2018, Jan;72(1):274-279 PMID: 29147836

Added to your cart

View Cart Checkout
Loading...